Drug Discovery Biology Strategy Meeting

As we look ahead to another exciting year, we're pleased to announce the schedule for Proventa International’s 2025 Strategy Meetings. Set in key locations across the US and UK, these gatherings are designed for industry leaders to connect, share insights, and push the boundaries of pharmaceutical and biotech research. 2025 Meeting Dates and Locations: 𝗨𝗦 𝗘𝗮𝘀𝘁 𝗖𝗼𝗮𝘀𝘁 - 𝗟𝗲 𝗠𝗲𝗿𝗶𝗱𝗶𝗲𝗻 𝗕𝗼𝘀𝘁𝗼𝗻 𝗖𝗮𝗺𝗯𝗿𝗶𝗱𝗴𝗲, 𝗠𝗔 May 7 - Chemistry, Manufacturing & Controls Strategy Meeting May 8 - Medicinal Chemistry Strategy Meeting 𝗨𝗦 𝗘𝗮𝘀𝘁 𝗖𝗼𝗮𝘀𝘁 - 𝗛𝘆𝗮𝘁𝘁 𝗥𝗲𝗴𝗲𝗻𝗰𝘆 𝗣𝗿𝗶𝗻𝗰𝗲𝘁𝗼𝗻, 𝗡𝗝 May 14 - Medicinal Chemistry Strategy Meeting May 15 - Clinical Operations & Clinical Trial Supply Chain Strategy Meeting 𝗘𝘂𝗿𝗼𝗽𝗲 - 𝗖𝗿𝗼𝘄𝗻𝗲 𝗣𝗹𝗮𝘇𝗮 𝗟𝗼𝗻𝗱𝗼𝗻 𝗗𝗼𝗰𝗸𝗹𝗮𝗻𝗱𝘀, 𝗟𝗼𝗻𝗱𝗼𝗻, 𝗨𝗞 October 21 - Drug Discovery Biology & Bioinformatics Strategy Meeting October 22 - Medicinal Chemistry Strategy Meeting 𝗨𝗦 𝗪𝗲𝘀𝘁 𝗖𝗼𝗮𝘀𝘁 - 𝗛𝗮𝗿𝗱 𝗥𝗼𝗰𝗸 𝗛𝗼𝘁𝗲𝗹 𝗦𝗮𝗻 𝗗𝗶𝗲𝗴𝗼, 𝗖𝗔 November 12 - Medicinal Chemistry Strategy Meeting November 13 - Clinical Operations & Clinical Trial Supply Chain Strategy Meeting 𝗨𝗦 𝗘𝗮𝘀𝘁 𝗖𝗼𝗮𝘀𝘁 - 𝗟𝗲 𝗠𝗲𝗿𝗶𝗱𝗶𝗲𝗻 𝗕𝗼𝘀𝘁𝗼𝗻 𝗖𝗮𝗺𝗯𝗿𝗶𝗱𝗴𝗲, 𝗠𝗔 November 18 - Clinical Operations & Clinical Trial Supply Chain Strategy Meeting November 19- Bioinformatics & Drug Discovery Biology Strategy Meeting Stay tuned for updates! Looking forward to seeing you at these key industry events throughout 2025! #StrategyMeetings #LifeSciences #Networking #Innovation #PharmaceuticalIndustry #Biotechnology #ClinicalOperations #MedicinalChemistry #DrugDiscovery #Bioinformatics #CMC #ClinicalOperations #PharmaLeaders

Right now at the Drug Discovery Strategy Meeting in Boston, attendees are engaging in personalized one-on-one meetings. These tailored discussions provide a unique platform for professionals to connect directly with solutions experts and industry leaders, fostering meaningful exchanges that are pivotal for future collaborations. It's the perfect environment for sparking new ideas and forging the connections that will drive tomorrow’s innovations in drug discovery. #DrugDiscovery #BostonEvents #Networking #StrategyMeeting #Innovation #Collaboration

We're underway with the first round of engaging roundtable discussions at today’s Drug Discovery Biology Strategy Meeting in Boston. Industry leaders and innovators are currently gathered at Le Meridien, diving deep into crucial topics from novel targeting mechanisms to the integration of artificial intelligence in drug development, shaping the future of drug discovery. It’s exciting to see so much expertise and enthusiasm concentrated in one room, all pushing forward the boundaries of what’s possible in pharmaceutical research. Stay connected for more insights as we continue to report from this vital gathering of minds in the heart of Boston. #DrugDiscovery #BostonEvents #StrategyMeeting #PharmaInnovation #RoundtableDiscussion

Today at Le Meridien Boston, the Drug Discovery Biology Strategy Meeting kicked off with an inspiring keynote by Larry Brown, Executive Vice President and Chief Scientific Officer at Noveome Biotherapeutics, Inc. Keynote Topic: "An Emerging Paradigm: Cellular Therapeutics without Cells" Larry R. Brown delved into the revolutionary approaches reshaping the landscape of cellular therapeutics. His presentation explored the forefront of biotechnological innovations, discussing how new therapies are being developed that harness the benefits of cellular mechanisms without using actual cells. This groundbreaking session provided attendees with a glimpse into the future of drug discovery, offering insights into novel therapeutic strategies that could potentially transform patient care. Stay tuned for more updates as we continue to explore cutting-edge developments in drug discovery here at the meeting. A Big Thank you to our sponsors! Sai Life Sciences Ltd Pelago Bioscience AB Revvity Signals Evotec Sapio Sciences Aragen Life Sciences Novalix #DrugDiscovery #BiologyStrategy #CellularTherapeutics #Innovation #BostonEvents #NoveomeBiotherapeutics

Today, leading minds in drug discovery are gathering to delve into the latest research, discuss innovative therapeutic strategies, and forge impactful collaborations at Le Meridien Boston Cambridge where the Drug Discovery Strategy Meeting This meeting presents a prime opportunity for professionals from diverse sectors of the pharmaceutical and biotechnology industries to connect, exchange ideas, and collaborate on pioneering projects. Keep an eye on our feed as we bring you live updates from the event, spotlight essential talks, and share insights from some of the top experts in the field. Don’t miss out on discovering how today’s collaborative efforts are setting the stage for tomorrow’s medical breakthroughs! #DrugDiscovery #BostonEvents #PharmaInnovation #Networking #Collaboration #HealthcareInnovation

5 Days Until the Drug Discovery Biology Strategy Meeting The excitement is building with only five days to go until the Drug Discovery Biology Strategy Meeting in Boston! Join us as we delve into innovative research and development strategies this November 12th. Looking forward to a day of insightful discoveries! #DrugDiscovery #BostonEvents #PharmaInnovation #StrategyMeeting

2 Weeks to Go! Explore the frontiers of biology in drug discovery at our Drug Discovery Biology Strategy Meeting. This is your opportunity to connect with top scientists and leaders driving advancements in this vital field. 📅 November 12 | 📍 Le Meridien Boston Cambridge https://lnkd.in/gvAny5yM #DrugDiscovery #Biology #BostonEvents #PharmaInnovation #Networking

We are honored to have Dr. Prasoon Chaturvedi, Vice President, Head of DMPK at C4 Therapeutics, as a facilitator at the upcoming Drug Discovery Strategy Meeting on November 12 at the Le Meridien Boston Cambridge. 𝗦𝗲𝘀𝘀𝗶𝗼𝗻 𝗧𝗼𝗽𝗶𝗰: "𝗔𝘀𝘀𝗲𝘀𝘀𝗶𝗻𝗴 𝗖𝘂𝗿𝗿𝗲𝗻𝘁 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗺𝗲𝗻𝘁𝘀 𝗶𝗻 𝗣𝗕𝗣𝗞 𝗔𝗯𝘀𝗼𝗿𝗽𝘁𝗶𝗼𝗻 𝗠𝗼𝗱𝗲𝗹𝗶𝗻𝗴 𝗮𝗻𝗱 𝗜𝘁𝘀 𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀" Dr. Chaturvedi brings over two decades of experience in drug metabolism and pharmacokinetics (DMPK), specializing in the development of protein degraders. His extensive work has spanned multiple therapeutic areas, including infectious disease, oncology, hematology, and more, contributing to several successful IND, CTA, and NDA filings. Under his leadership, DMPK efforts have supported the development and market success of drugs such as NUZYRA® and ONPATTRO®. With a Ph.D. from IIT Roorkee and post-doctoral training at the E.K. Shriver Center of Harvard Medical School, Dr. Chaturvedi's expertise is unparalleled. Join us as Dr. Chaturvedi sheds light on the sophisticated world of PBPK modeling, discussing the latest advancements and navigating the complexities that come with these innovations in drug discovery. Don't miss this opportunity to gain invaluable insights from a leading expert in the field. https://lnkd.in/gvAny5yM #DrugDiscovery #DMPK #PBPKModeling #PharmaIndustry #BostonEvents #ClinicalPharmacology #C4Therapeutics

During this afternoon's keynote at the 𝗟𝗼𝗻𝗱𝗼𝗻 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗕𝗶𝗼𝗹𝗼𝗴𝘆 & 𝗕𝗶𝗼𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗰𝘀 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝘆 𝗠𝗲𝗲𝘁𝗶𝗻𝗴, Pelago Bioscience AB's Dr. Stina Lundgren took center stage to discuss "𝗧𝗵𝗲 𝗖𝗲𝗹𝗹𝘂𝗹𝗮𝗿 𝗧𝗵𝗲𝗿𝗺𝗮𝗹 𝗦𝗵𝗶𝗳𝘁 𝗔𝘀𝘀𝗮𝘆: 𝗛𝗼𝘄 𝗔𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁 𝗼𝗳 𝗧𝗮𝗿𝗴𝗲𝘁 𝗘𝗻𝗴𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗔𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗲𝘀 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆." Her exploration of CETSA illuminated its critical role in the drug discovery landscape. 𝗞𝗲𝘆 𝗣𝗼𝗶𝗻𝘁𝘀 𝗖𝗼𝘃𝗲𝗿𝗲𝗱: - 𝗟𝗶𝘃𝗲 𝗖𝗲𝗹𝗹 𝗛𝗶𝘁 𝗖𝗼𝗻𝗳𝗶𝗿𝗺𝗮𝘁𝗶𝗼𝗻: CETSA enables the confirmation of hits directly in live cells, which streamlines the validation process without any modifications to the cells or compounds involved. - 𝗣𝗿𝗶𝗺𝗮𝗿𝘆 𝗦𝗰𝗿𝗲𝗲𝗻𝗶𝗻𝗴 𝗔𝗱𝘃𝗮𝗻𝘁𝗮𝗴𝗲𝘀: CETSA proves invaluable for addressing complex targets right from the initial screening phase, thereby enhancing the overall efficacy of drug discovery pipelines. - 𝗗𝗲𝘁𝗮𝗶𝗹𝗲𝗱 𝗦𝗲𝗹𝗲𝗰𝘁𝗶𝘃𝗶𝘁𝘆 𝗣𝗿𝗼𝗳𝗶𝗹𝗶𝗻𝗴: Through unbiased selectivity profiling, CETSA helps identify potential therapeutic liabilities early, ensuring the selection of more efficacious candidates. The insights provided by Pelago Bioscience today have enriched our understanding of modern methodologies in drug discovery, promising to shape future innovations in the field. 𝗔 𝗯𝗶𝗴 𝘁𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 to Pelago Bioscience AB for the partnership and Dr. Lundgren for her expert insights that are helping pave the way for future advancements in the field. #DrugDiscovery #Bioinformatics #PelagoBioscience #CETSA #Innovation #PharmaIndustry #BiotechEvents